We use cookies to provide you with a better experience. By continuing to browse the site you are agreeing to our use of cookies in accordance with our Cookie Policy.
Accept
Home » FDA Urges Genetic Test for Some Considering Carbamazepine
FDA Urges Genetic Test for Some Considering Carbamazepine
December 14, 2007
Drugs containing carbamazepine will now include on their labeling a recommendation that, before starting treatment, patients with Asian ancestry get a genetic test that can identify an increased risk of developing a rare but serious side effect.